Have a personal or library account? Click to login
When Maxillofacial CBCT Permits Fortuitously to Diagnose Primary Non-Hodgkin’s Lymphoma: A Case Report Cover

When Maxillofacial CBCT Permits Fortuitously to Diagnose Primary Non-Hodgkin’s Lymphoma: A Case Report

Open Access
|Sep 2024

Figures & Tables

jbsr-108-1-3682-g1.jpg
Figure 1

Intra-oral photography of the first endodontic consultation.

jbsr-108-1-3682-g2.jpg
Figure 2

Retro-alveolar radiography at the first appointment.

jbsr-108-1-3682-g3.jpg
Figure 3

Computed tomography showing a large osteolytic area between left sinus and left upper molars (10 x10 cm (668 x 668 x 668)- 0,150 mm- 90 kV-8 mA 15,117s, ROMEXIS software).

jbsr-108-1-3682-g4.jpg
Figure 4

Histological analysis. A. A23 03155 HES_33.3x.: hematoxylin-eosin-safran (HES) coloration, original x33,3 magnification, tumor infiltration in sheets of non-cohesive cells, often crushed, of medium to large size, with barely visible cytoplasm, poorly nucleolated nucleus. Presence of apoptosis images. B. A23 03155 CD20_35 5x: immunohistochemical study using anti-CD20 antibody, original magnification x 35.5, diffuse positivity of all tumor cells in favor of proliferation of B lymphocytes C. A23 03155 KI67_17.6x: immunohistochemical study using the anti-KI67 antibody, original magnification x17.6, highlighting a high proliferation index, in favor of an aggressive B lymphoma.

jbsr-108-1-3682-g5.jpg
Figure 5

PET-SCAN after diagnosis and three months later after treatment.

jbsr-108-1-3682-g6.jpg
Figure 6

Radiography retro-alveolar post treatment (note the new densification around teeth).

DOI: https://doi.org/10.5334/jbsr.3682 | Journal eISSN: 2514-8281
Language: English
Submitted on: Jun 27, 2024
Accepted on: Aug 13, 2024
Published on: Sep 5, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Pierre-Louis Polard, Adrian Tempescul, Karen Vallaeys, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.